Vol 10, Supp. B (2019)
Case report
Published online: 2019-10-02
Long-term efficacy of azacitidine in a patient with acute myeloid leukemia with myelodysplastic-related changes
Abstract
Azacitidine is a hypomethylating agent, commonly used in treatment of acute myeloid leukemia with 20–30% bone marrow blasts. We present a case of a long-term efficacy of this drug used in the patient for 36 months.
Keywords: acute myeloid leukemiaazacitidinelong-term efficacy